In terms of liquidity and interest, the mean open interest for Regeneron Pharmaceuticals options trades today is 96.18 with a ...

Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

This article updates on two key legal cases in healthcare enforcement. First, in Regeneron, after the First Circuit ruled ...

Two Farragut High School Seniors were among 300 chosen in the 2026 Regeneron Science Talent Search math and science ...

A $3 billion agreement with Regeneron will expand biopharmaceutical production in North Carolina, creating 1,400 jobs by 2031 ...

It’s been more than ten years since the FDA signed off on the United States’ first biosimilar product, opening up what was ...

Quick Read FBT returned 29% over the past year and gained 5.4% in the first week of 2026. Federal Reserve officials forecast ...

Ultragenyx Pharmaceutical and Mereo BioPharma Group saw their shares plummet after ringing out 2025 by announcing the failures of their brittle bone disease candidate setrusumab (UX143) in a pair of ...

As of Wednesday, January 07, CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.40%, which has investors questioning if this is right time to sell.

The pharmaceutical company agreed to offer lower-cost drugs on the not-yet-available TrumpRx website and build facilities in Pennsylvania and North Carolina. It did not disclose how long its tariff ...

Pope Leo XIV has closed the Vatican's 2025 Holy Year, marking the end of a yearlong celebration that drew 33 million pilgrims ...